BioSig Technologies, Inc. (NASDAQ:BSGM – Get Free Report)’s stock price was down 2.6% during trading on Tuesday . The stock traded as low as $1.00 and last traded at $1.13. Approximately 192,145 shares were traded during trading, an increase of 43% from the average daily volume of 134,604 shares. The stock had previously closed at $1.16.
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets raised their target price on shares of BioSig Technologies from $2.50 to $2.75 and gave the company a “buy” rating in a research note on Thursday, December 5th.
Get Our Latest Analysis on BSGM
BioSig Technologies Stock Performance
About BioSig Technologies
BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.
Read More
- Five stocks we like better than BioSig Technologies
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Insider Buying Explained: What Investors Need to Know
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Insider Trades May Not Tell You What You Think
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
